PARKINSON’S DISEASE: A PHYTOCHEMICAL APPROACH

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Amantadine for Levodopa-Induced Dyskinesias

  2016cited by this paper
• Neuroprotective Role of Withania somnifera Root Extract in Maneb–Paraquat Induced Mouse Model of Parkinsonism

  2013cited by this paper
• Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson's Disease Model

  2013cited by this paper
• Resveratrol Confers Protection against Rotenone-Induced Neurotoxicity by Modulating Myeloperoxidase Levels in Glial Cells

  2013cited by this paper
• Frontiers in Research: Herbal Bioactive Molecules: The Hidden Jewels for Drug Development Discovery of curcumin, a component of golden spice, and its miraculous biological activities

  2012cited by this paper
• Neuroprotective Effect of Curcuminoids Against Inflammation-Mediated Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

  2012cited by this paper
• Curcumin Protects Nigrostriatal Dopaminergic Neurons and Reduces Glial Activation in 6-Hydroxydopamine Hemiparkinsonian Mice Model

  2012cited by this paper
• Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse.

  2012cited by this paper
• The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate

  2012cited by this paper
• Tenuigenin Protects Dopaminergic Neurons from Inflammation‐Mediated Damage Induced by the Lipopolysaccharide

  2012cited by this paper
• Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.

  2011cited by this paper
• Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.

  2011cited by this paper
• Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury.

  2011cited by this paper
• Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice

  2011cited by this paper
• Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs

  2011cited by this paper
• Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches.

  2010cited by this paper
• Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells.

  2010cited by this paper
• Biosynthesis and characterization of gold nanoparticle using antiparkinsonian drug Mucuna pruriens plant extract

  2010cited by this paper
• Effect of Bacopa monniera Linn. (brahmi) extract on learning and memory in rats: A behavioral study

  2010cited by this paper
• Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats.

  2010cited by this paper
• A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

  2010cited by this paper
• Bacopa monniera protects rat heart against ischaemia–reperfusion injury: role of key apoptotic regulatory proteins and enzymes

  2010cited by this paper
• Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages.

  2009cited by this paper
• Levodopa-related wearing-off in Parkinson's disease: identification and management

  2009cited by this paper
• Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson’s Disease

  2009cited by this paper
• Prognostic Factors of Subthalamic Stimulation in Parkinson’s Disease: A Comparative Study between Short- and Long-Term Effects

  2009cited by this paper
• Cell replacement therapy for Parkinson's disease.

  2009cited by this paper
• Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster.

  2009cited by this paper
• Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.

  2009cited by this paper
• Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.

  2009cited by this paper
• Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.

  2008cited by this paper
• Dopamine agonist-based strategies in the treatment of Parkinson’s disease

  2008cited by this paper
• Deep Brain Stimulation

  2008cited by this paper
• Effect of Centella asiatica leaf powder on oxidative markers in brain regions of prepubertal mice in vivo and its in vitro efficacy to ameliorate 3-NPA-induced oxidative stress in mitochondria.

  2008cited by this paper
• Effect of Cabergoline on Parkinsonian Tremor Assessed by Long-Term Actigraphy

  2008cited by this paper
• A review of Parkinson's disease.

  2008cited by this paper
• Deep brain stimulation and tremor

  2008cited by this paper
• Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease

  2008cited by this paper
• Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile.

  2008cited by this paper
• Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging.

  2008cited by this paper
• Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice.

  2008cited by this paper
• Inflammation as a causative factor in the aetiology of Parkinson's disease

  2007cited by this paper
• Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of ‘off’ episodes in patients with Parkinson's disease

  2007cited by this paper
• A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2.

  2007cited by this paper
• REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia

  2007cited by this paper
• Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease.

  2007cited by this paper
• Protective effect of Centella asiatica extract and powder on oxidative stress in rats

  2007cited by this paper
• Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor

  2006cited by this paper
• Chronic systemic D‐galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: Protective effects of R‐α‐lipoic acid

  2006cited by this paper
• Mechanism of over-activation in direct pathway mediated by dopamine D₁ receptor in rats with levodopa-induced dyskinesia.

  2006cited by this paper
• Anti-inflammatory activity of Bacopa monniera in rodents.

  2006cited by this paper
• Studies on antiaging action of Polygala tenuifolia Wild.

  2006cited by this paper
• Antioxidative and Anti-Inflammatory Activities of Polyhydroxyflavonoids of Scutellaria baicalensis GEORGI

  2006cited by this paper
• Ferritin oxidation and proteasomal degradation: Protection by antioxidants

  2006cited by this paper
• Phenolic contents and antioxidant activity of some food and medicinal plants

  2005cited by this paper
• Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

  2005cited by this paper
• Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences

  2005cited by this paper
• Antioxidant approach to disease management and the role of 'Rasayana' herbs of Ayurveda.

  2005cited by this paper
• EGb761 Pretreatment Reduces Monoamine Oxidase Activity in Mouse Corpus Striatum During 1-Methyl-4-Phenylpyridinium Neurotoxicity

  2004cited by this paper
• Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate.

  2004cited by this paper
• Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells

  2004cited by this paper
• The Ups and Downs of Parkinson Disease: A Prospective Study of Mood and Anxiety Fluctuations

  2004cited by this paper
• Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease

  2004cited by this paper
• Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.

  2003cited by this paper
• Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function.

  2003cited by this paper
• Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats.

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro.

  2002cited by this paper
• Neuroprotective and neurorestorative strategies for Parkinson's disease

  2002cited by this paper
• Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells.

  2002cited by this paper
• Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus

  2000cited by this paper
• Biological effects of resveratrol.

  2000cited by this paper
• Apomorphine: An underutilized therapy for Parkinson's disease

  2000cited by this paper
• Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.

  1999cited by this paper
• Parkinson disease in twins: an etiologic study.

  1999cited by this paper
• Nonpharmacologic management strategies.

  1999cited by this paper
• Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson’s disease

  1998cited by this paper
• Effects of ginsenoside Rb1 and Rg1 on synaptosomal free calcium level, ATPase and calmodulin in rat hippocampus.

  1995cited by this paper
• Psychotic symptoms in patients with dementia

  1995cited by this paper
• Catechol‐O‐methyltransferase inhibition increases striatal L‐dopa and dopamine

  1992cited by this paper
• Blinded evaluation confirms long‐term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease

  1992cited by this paper
• An estimate of the incidence of depression in idiopathic Parkinson's disease.

  1992cited by this paper
• Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.

  1990cited by this paper
• Treatment of Parkinson's disease with the cowhage plant-Mucuna pruriens Bak.

  1978cited by this paper
• Isolation of l-3:4-dihydroxyphenylalanine from the seeds of Mucuna pruriens.

  1937cited by this paper

• Nanostarch based nanoencapsulation of Mucuna pruriens extract and its evaluation as anti-parkinsonian drug

  2023cites this paper
• Beneficial Effects of Sesamol, Hesperidin, Quercetin and Phloroglucinol in Parkinson’s Disease Models- A Review

  2018cites this paper